15 December 2002
Ann Transplant 2003; 8(4): 57-62 :: ID: 7568
Objectives. Gingival overgrowth is a common side effect of cyclosporine A (CsA) therapy. The pathogenesis of CsA-induced gingival overgrowth
is still debated. The influence of CsA dosage and its trough level, HLA phenotype, gender and the administered calcium channel blocker on
incidence and severity of overgrowth were studied. Moreover, relationship of overgrowth with plasma level of TGF-beta 1 was assessed.
Methods. Degree and extent of gingival overgrowth were tested in 124 kidney transplant recipients treated with CsA, in 9 patients treated with
azathioprine and in 21 patients treated with tacrolimus, and various calcium channel blockers.
Results. Gingival overgrowth was found in 46% of patients treated with CsA. Total yearly CsA dosage was significantly higher in patients with
overgrowth. Gingival overgrowth was observed in: 86% of patients treated with nifedipin, 47% with amlodipin, 35% with verapamil. HLA-DR
antigens analysis showed that half of the patients with DR-2 allele suffered from overgrowth. Gingival overgrowth was found twice as often in males than in females. Plasma level of TGF-beta1 was similar in patients with or without overgrowth. Gingival overgrowth was not found in patients treated with azathioprine or tacrolimus despite that half of the patients received nifedipine or amlodipine.
Conclusions. The study revealed high frequency of overgrowth in renal graft recipients treated with CsA. Overgrowth severity was larger in
patients treated simultaneously with nifedipine or amlodipine. CsA dosage, male sex and HLA-DR2 phenotype were risk factors of gingival
overgrowth. None of the patients treated with tacrolimus suffered from gingival overgrowth.
Keywords: Alleles, Amlodipine - adverse effects, Calcium Channel Blockers - adverse effects, Cyclosporine - adverse effects, Gingival Overgrowth - etiology, Gingival Overgrowth - genetics, Gingival Overgrowth - immunology, HLA-DR2 Antigen - genetics, Immunosuppressive Agents - adverse effects, Kidney Transplantation - adverse effects, Kidney Transplantation - immunology, Nifedipine - adverse effects, Risk Factors, Risk Factors, Sex Factors
14 Sep 2023 : Case reportIntrahepatic Venous Collateral Circulation and Reverse Blood Flow After Main Hepatic Vein Obstruction: A Ca...
Ann Transplant In Press; DOI: 10.12659/AOT.941521
12 Sep 2023 : Original articleThree-Dimensional Printing of Polycaprolactone/Nano-Hydroxyapatite Composite Scaffolds with a Pore Size of ...
Ann Transplant In Press; DOI: 10.12659/AOT.940365
04 Sep 2023 : Original articleAnalysis of Anxiety and Influencing Factors in Kidney Transplant Recipients and General Public During the C...
Ann Transplant In Press; DOI: 10.12659/AOT.941489
Most Viewed Current Articles
24 Aug 2021 : Review articleNormothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives
Ann Transplant 2021; 26:e931664
26 Jan 2022 : Review articleRecurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
Ann Transplant 2022; 27:e934924
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588